Baseline characteristics at the time of HIV-MCD diagnosis (n = 52)
| Characteristic . | Value . |
|---|---|
| Male/female, n | 50/2 |
| Age, y (range) | 42.8 ± 9.6 (28.4-68.3) |
| Time since first positive HIV serology, y (range) | 4.3 ± 4.6 (0.3-18.0) |
| Time since first documented HIV-MCD symptoms, y (range) | 0.9 ± 1.2 (0.02-5.3) |
| Prior AIDS diagnosis, n (%) | 35 (67) |
| Prior KS diagnosis, n (%) | 32 (62) |
| Prior or current ART, n (%) | 40 (80) |
| Clinical symptoms | |
| Fever, n (%) | 50 (100) |
| Lymphadenopathy, n (%) | 51 (98) |
| Splenomegaly, n (%) | 50 (98) |
| Pulmonary symptoms, n (%) | 30 (61) |
| Edema, n (%) | 19 (41) |
| Immunologic, virologic, and other parameters | |
| Absolute CD4 T-cell counts, cells/μL (range) | 287 ± 206 (21-1038) |
| Relative CD4 T-cell counts, % (range) | 17 ± 9 (0-35) |
| HIV-RNA < 50 copies/mL in patients on ART, n (%) | 22 (50) |
| HIV-RNA < 400 copies/mL in patients on ART, n (%) | 27 (61) |
| Hemoglobin, g/dL (range) | 9.6 ± 1.8 (5.7-13.1) |
| Thrombocytes, 1/μL (range) | 173 ± 116 (22-544) |
| Characteristic . | Value . |
|---|---|
| Male/female, n | 50/2 |
| Age, y (range) | 42.8 ± 9.6 (28.4-68.3) |
| Time since first positive HIV serology, y (range) | 4.3 ± 4.6 (0.3-18.0) |
| Time since first documented HIV-MCD symptoms, y (range) | 0.9 ± 1.2 (0.02-5.3) |
| Prior AIDS diagnosis, n (%) | 35 (67) |
| Prior KS diagnosis, n (%) | 32 (62) |
| Prior or current ART, n (%) | 40 (80) |
| Clinical symptoms | |
| Fever, n (%) | 50 (100) |
| Lymphadenopathy, n (%) | 51 (98) |
| Splenomegaly, n (%) | 50 (98) |
| Pulmonary symptoms, n (%) | 30 (61) |
| Edema, n (%) | 19 (41) |
| Immunologic, virologic, and other parameters | |
| Absolute CD4 T-cell counts, cells/μL (range) | 287 ± 206 (21-1038) |
| Relative CD4 T-cell counts, % (range) | 17 ± 9 (0-35) |
| HIV-RNA < 50 copies/mL in patients on ART, n (%) | 22 (50) |
| HIV-RNA < 400 copies/mL in patients on ART, n (%) | 27 (61) |
| Hemoglobin, g/dL (range) | 9.6 ± 1.8 (5.7-13.1) |
| Thrombocytes, 1/μL (range) | 173 ± 116 (22-544) |
Values are mean ± SD, if not otherwise indicated. The percentages were calculated from the patients with available data on each parameter.